BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 307723)

  • 21. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T and B lymphocyte function in patients with lupus nephritis: correlation with renal pathology.
    Balow JE; Tsokos GC
    Clin Nephrol; 1984 Feb; 21(2):93-7. PubMed ID: 6233052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cell activity and regulatory T cell function in systemic lupus erythematosus by human B cell colony formation.
    Otsuka T; Okamura S; Niho Y; Kusaba T
    J Rheumatol; 1985 Jun; 12(3):508-13. PubMed ID: 2864442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of circulating immunoblasts in the peripheral blood of patients with systemic lupus erythematosus and other rheumatic diseases].
    Bulanova TD; le Go A; Alekberova ZS; Polianskaia IP
    Ter Arkh; 1980; 52(6):64-7. PubMed ID: 6967635
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immune adherence reaction in systemic lupus erythematosus and glomerulonephritis].
    Arustamova RG; Gordovskaia NB; Adnoral SA; Kalina II; Traianova TG
    Ter Arkh; 1975; 47(4):64-70. PubMed ID: 1079973
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
    Kumagai S; Steinberg AD; Green I
    J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus.
    Utsinger PD
    J Rheumatol; 1976 Jun; 3(2):175-85. PubMed ID: 1084929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of T and B lymphocytes in the pathogenesis of systemic lupus erythematosus].
    Gliński W
    Przegl Dermatol; 1976; 63(4):505-12. PubMed ID: 788057
    [No Abstract]   [Full Text] [Related]  

  • 29. Similar disturbances in B cell activity and regulatory T cell function in Henoch-Schönlein purpura and systemic lupus erythematosus.
    Beale MG; Nash GS; Bertovich MJ; MacDermott RP
    J Immunol; 1982 Jan; 128(1):486-91. PubMed ID: 6976380
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of the inflammatory infiltrate in lupus erythematosus lesions using monoclonal antibodies.
    Synkowski DR; Provost TT
    J Rheumatol; 1983 Dec; 10(6):920-4. PubMed ID: 6607342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The production of antibody-dependent cellular cytotoxicity by immune complexes in systemic lupus erythematosus.
    Penning CA; Hughes P; Rowell NR
    J Clin Lab Immunol; 1984 Mar; 13(3):123-7. PubMed ID: 6716450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease.
    Kallenberg CG; van Dissel-Emiliani F; Huitema MG; Limburg PC; The TH
    J Clin Lab Immunol; 1988 Jun; 26(2):55-61. PubMed ID: 3264025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison between anti-lymphocyte antibodies in systemic lupus erythematosus and in Hodgkin's disease].
    Del Giacco GS; Leone AL; Locci F; Manconi PE; Tognella S; Mantovani G; Grifoni V
    Boll Ist Sieroter Milan; 1976 Jul; 55(3):255-61. PubMed ID: 1087885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
    Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
    Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [NZB/W mice: an animal model of systemic lupus erythematosus].
    Gliński W
    Przegl Dermatol; 1976; 63(2):217-23. PubMed ID: 1083547
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum-induced enhancement of peripheral blood mononuclear cell mediated cytotoxicity towards human target cells in systemic lupus erythematosus.
    Wright JK; Penning CA; Ashby JC; Cunningham J; Rowell NR; Hughes P
    J Clin Lab Immunol; 1983 Jun; 11(2):81-5. PubMed ID: 6876144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmapheresis in systemic lupus erythematosus: effects on cellular immunity.
    Vangelista A; Frascà GM; Nanni-Costa A; Bonomini V
    Trans Am Soc Artif Intern Organs; 1983; 29():749-53. PubMed ID: 6608818
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphocytotoxic antibodies in mexican patients with systemic lupus erythematosus and their families relationship of disease activity in the probands to antibody cytotoxicity in their relatives.
    DeHoratius RJ; Alarcón-Segovia D; Messner RP; Fishbein E
    Rev Invest Clin; 1981; 33(2):161-4. PubMed ID: 7291760
    [No Abstract]   [Full Text] [Related]  

  • 39. Monocyte-specific antigens--detection by the antibody-dependent cellular cytotoxicity (ADCC) method.
    Johny M; Pazderka F; Kovithavongs T; Schlaut J; Dossetor JB
    Transplant Proc; 1979 Dec; 11(4):1970-3. PubMed ID: 93817
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of rosette-forming lymphocytes in peripheral blood of patients with systemic lupus erythematosus].
    Komarov FI; Savel'ev AI; Frumina EI; Pukhal'skiĭ AL; Gutorova NM
    Ter Arkh; 1974; 46(11):78-82. PubMed ID: 4548225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.